MULTI-LINK RX VISION CORONARY STENT SYSTEM
Report
- Report Number
- 2024168-2010-02368
- Event Type
- Injury
- Date Received
- November 5, 2010
- Date of Event
- April 27, 2010
- Report Date
- October 13, 2010
- Manufacturer
- ABBOTT VASCULAR-CARDIAC THERAPIES
- Product Code
- MAF
- PMA / PMN Number
- P020047
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(4). THERE WAS NO REPORTED PRODUCT DEFICIENCY. THE REPORTED PT EFFECT OF RESTENOSIS, AS LISTED IN THE VISION INSTRUCTIONS FOR USE (IFU) IS A KNOWN ADVERSE EVENT ASSOCIATED WITH CORONARY STENTING PROCEDURES. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING. THE 3.0 X 23 MM MULTI-LINK RX VISION (PART 1007842-23J, LOT UNK), INDICATED IS BEING FILE UNDER A SEPARATE MFR#.
IT WAS REPORTED THAT TWO VISION STENTS WERE IMPLANTED IN THE RCA LESION ON (B)(6) 2009. ON (B)(6) 2010, A 3.5 X 28 MM AND A 3.5 X 18 MM XIENCE V STENT WERE IMPLANTED IN THE LESION BECAUSE OF THE RESTENOSIS OF THE VISION STENTS. THE STENOSIS IMPROVED FROM 90% TO 0%. THE VESSEL DIAMETER AND LENGTH IN WHICH XIENCE V STENTS WERE IMPLANTED: 3.5 MM AND 40 MM. NO PT EFFECTS WERE REPORTED. NO ADDITIONAL INFO WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | MULTI-LINK RX VISION CORONARY STENT SYSTEM | MAF | ABBOTT VASCULAR-CARDIAC THERAPIES | NA | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | UNK | Hospitalization| R | MULTI-LINK RX VISION (PART 1007842-23J, LOT UNK)| STENT: 3.0 X 23 MM| GUIDE: CATH: HEARTRAIL 6F IR1.0| VOYAGER NC 3.5 X 15MM| DILATATION CATHETER: TAZUNA 3.0 X 15MM| HIRYU 3.5 X 20MM| GUIDE WIRE: RUNTHOUGH, EXTRA FLOPPY, PT2 |